76 results
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
and not customer-facing personnel in the field to support the company’s long-term growth and profitability.
For the full-year and first-quarter of 2024
8-K
EX-99.1
NVRO
Nevro Corp
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
employees and not customer-facing personnel in the field.
Financial Highlights
Fourth-quarter 2023 worldwide revenue of approximately $116.0
8-K
EX-10.1
NVRO
Nevro Corp
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act and the Beneficial
8-K
EX-2.1
NVRO
Nevro Corp
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
competitor, supplier, licensor, distributor, lessor, independent contractor or customer of the Company (it being
agreed, however, that the passive … , payment of trade accounts payable, accrual of other expenses, deferral of revenue and acceptance of customer deposits;
(h) incurrence, assumption
8-K
EX-99.1
4krrwu71 qo0
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
7iyv 9n142hg
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
f72s6kl 0z
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
c2cwb6egv 62rpgz83
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
w4v953wsxq3lz55k
8 Nov 21
Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance
4:18pm